IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity
- 1 January 2017
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 5 (1) , 61-71
Abstract
Immune cells constitute a large fraction of the tumor microenvironment and modulate tumor progression. Clinical data indicate that chronic inflammation is present at tumor sites and that IL4 in particular is upregulated. Here, we demonstrate that T follicular helper (Tfh) cells arise in tumor-draining lymph nodes where they produce an abundance of IL4. Deletion of IL4-expressing Tfh cells improves antitumor immunity, delays tumor growth, and reduces the generation of immunosuppressive myeloid cells in the lymph nodes. These findings suggest that IL4 from Tfh cells affects antitumor immunity and constitutes an attractive therapeutic target to reduce immunosuppression in the tumor microenvironment, and thus enhance the efficacy of cancer immunotherapy. Cancer Immunol Res; 5(1); 61–71. ©2016 AACR.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- CD4+ follicular helper T cell infiltration predicts breast cancer survivalJournal of Clinical Investigation, 2013
- Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironmentInternational Journal of Cancer, 2012
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironmentClinical and Experimental Immunology, 2012
- Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammationJournal of Experimental Medicine, 2011
- Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanomaJournal of Experimental Medicine, 2010
- Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsJournal of Experimental Medicine, 2010
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Myeloid-Derived Suppressor Cells: Linking Inflammation and CancerThe Journal of Immunology, 2009
- Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic MelanomaClinical Cancer Research, 2009
- Immune responses in the draining lymph nodes against cancer: Implications for immunotherapyCancer and Metastasis Reviews, 2006